Login to Your Account

Washington Roundup

Advanced Cell Technology Hit with SEC Complaint

By Mari Serebrov
Washington Editor

Friday, June 1, 2012
WASHINGTON – Advanced Cell Technology Inc. (ACT) has hit a bump in the road, but this one isn't related to its human embryonic stem cell program.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription